Career history of David Solomon
Former positions of David Solomon
Companies | Position | Start | End |
---|---|---|---|
MITHRA PHARMACEUTICALS S.A. | Chief Executive Officer | 2023-04-10 | 2024-03-04 |
PHARNEXT SCA | Director/Board Member | 2020-07-16 | 2022-11-26 |
Chief Executive Officer | 2020-04-15 | 2022-11-26 | |
ADVICENNE | Chairman | 2019-12-22 | 2022-06-08 |
Independent Dir/Board Member | 2019-12-22 | 2022-06-08 | |
Investor Relations Contact | 2019-12-22 | 2022-06-08 | |
SILENCE THERAPEUTICS PLC | Director/Board Member | 2018-08-19 | 2019-12-31 |
Chief Executive Officer | 2018-08-19 | 2019-12-31 | |
TXCELL | Director/Board Member | 2014-03-31 | 2018-10-31 |
Independent Dir/Board Member | 2014-03-31 | 2018-10-31 | |
Sund Capital ApS
Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Chief Executive Officer | 2016-08-31 | 2018-08-31 |
AKARI THERAPEUTICS, PLC | Chief Executive Officer | 2017-08-27 | 2018-05-07 |
Promosome LLC
Promosome LLC BiotechnologyHealth Technology Promosome LLC is a biotechnology company specializing in technologies related to the regulation of protein synthesis through translation initiation. Its proprietary mRNA engineering technology exploits features of the natural translation process in both prokaryotic and eukaryotic cells. The technologies involve recoding mRNAs for biotherapeutic agents to enhance ribosome recruitment, eliminate false starts in translation initiation, and ensure message stability in both eukaryotic and prokaryotic cells. Promosome was founded by William J. Gedale and John R. Costantino in 2003 and is headquartered in New York, NY. | Chairman | 2015-12-31 | 2016-12-31 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Chief Executive Officer | 2015-01-08 | 2016-04-30 |
President | 2015-01-08 | 2016-04-30 | |
░░░░░░░ ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ ░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Training of David Solomon
Weill Cornell Medical College | Doctorate Degree |
Statistics
International
United States | 8 |
United Kingdom | 5 |
France | 5 |
Operational
Chief Executive Officer | 9 |
Director/Board Member | 6 |
Chairman | 4 |
Sectoral
Health Technology | 14 |
Commercial Services | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 7 |
---|---|
SILENCE THERAPEUTICS PLC | Commercial Services |
VALERIO THERAPEUTICS | Health Technology |
MITHRA PHARMACEUTICALS S.A. | Health Technology |
ZEALAND PHARMA A/S | Health Technology |
PHARNEXT SCA | Health Technology |
ADVICENNE | Health Technology |
AKARI THERAPEUTICS, PLC | Health Technology |
Private companies | 13 |
---|---|
Promosome LLC
Promosome LLC BiotechnologyHealth Technology Promosome LLC is a biotechnology company specializing in technologies related to the regulation of protein synthesis through translation initiation. Its proprietary mRNA engineering technology exploits features of the natural translation process in both prokaryotic and eukaryotic cells. The technologies involve recoding mRNAs for biotherapeutic agents to enhance ribosome recruitment, eliminate false starts in translation initiation, and ensure message stability in both eukaryotic and prokaryotic cells. Promosome was founded by William J. Gedale and John R. Costantino in 2003 and is headquartered in New York, NY. | Health Technology |
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Health Technology |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
Vital Sensors Holding Co., Inc.
Vital Sensors Holding Co., Inc. Electronic Equipment/InstrumentsElectronic Technology Vital Sensors Holding Co., Inc. Develops chip based pressure sensors. It offers continuous or on demand data capture and read out capabilities that will support clinicians and patients in the management of cardiovascular and other disease state. The company was founded in 2002 by Volker Bödecker and Max Georg Ostermeier and is headquartered in Richmond, VA. | Electronic Technology |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
Solomons Ltd. | |
American Chamber of Commerce In Denmark
American Chamber of Commerce In Denmark Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Denmark is an organization that provides news, events, membership forums, and resources related to business in Denmark. The American Chamber of Commerce in Denmark is based in Copenhagen, Denmark. The organization focuses on promoting transatlantic data flows and foreign direct investments. Recently, the Danish government announced that it will invest 143 billion kroner in defense over the next decade. The organization also holds more than 50 events a year, including seminars and workshops on topics such as workforce planning and Danish taxation for expats. | Commercial Services |
Vital Sensors, Inc. | Health Technology |
The Cass Foundation | |
Sund Capital ApS
Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Finance |
Silence Therapeutics GmbH
Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David Solomon
- Experience